about
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expressionThe effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin.Affibody-mediated PET imaging of HER3 expression in malignant tumours.PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.Synthesis of 11C-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [11C]CO.In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6.Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX.Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m.Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression.Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and 177Lu labeling.Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptakeRadiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer. Influence of Labeling Chemistry on Targeting Properties
P50
Q33920975-73341EFC-DDA1-4FDC-9038-15435102BD86Q34996772-787DBC5B-C8D4-4254-9C8B-C7A917B9D7CAQ35208747-EFAF191F-4E0B-4456-8E63-6E424E85DCD9Q36174716-FA65C62B-0989-4477-9DF2-77FC8EDDE9D3Q36649532-FF24097B-3C7E-4096-A4BD-DF7C66C2D975Q37427038-699C48CF-BE2B-4523-92D1-D44F51FBF168Q37515306-F9446C1A-EA5F-4858-BEAD-D0831E779E16Q37660979-D232DA48-48F1-4E6C-A6DD-BEFE286843A6Q38741232-28420F91-46F3-4B89-8455-87BC192E7839Q38751583-5F7C4A8D-EFC9-46F7-A9BD-7D40483836E4Q38785819-DC6A4C2B-23DA-4FBA-B1BB-0351D62158ABQ38812258-BE28F060-16ED-4D45-8989-43E81DF583E7Q38909220-3EDF7464-FCE6-432F-89BD-46EEF24685F5Q43216601-8C3B987B-5EE3-47E9-936B-331987C847DDQ46219345-9D1F360F-7156-4734-A2F7-90095DEDC657Q47158578-8A773123-DCFD-4D80-8C12-D7EBE439605BQ47641731-7DAA721D-D905-46A5-97AA-167709884D6DQ47867757-95CA8AA7-008B-427D-8F89-A3C5A9BF762EQ47950527-D751D5D9-59AF-4B05-BBE5-3A88CE13B9B8Q50866938-4AAAC3D5-0E0B-49EC-AA71-73BD51C801FEQ55425539-8AB77BAF-349F-4BD6-9E06-EA59BE1F4CE2Q64077012-B8CB2148-620C-456D-AC09-19959FAB30DEQ90272896-8AB05AB2-49F1-4E3B-9BC5-8EF62E618855
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bogdan Mitran
@ast
Bogdan Mitran
@en
Bogdan Mitran
@es
Bogdan Mitran
@nl
type
label
Bogdan Mitran
@ast
Bogdan Mitran
@en
Bogdan Mitran
@es
Bogdan Mitran
@nl
prefLabel
Bogdan Mitran
@ast
Bogdan Mitran
@en
Bogdan Mitran
@es
Bogdan Mitran
@nl
P106
P1153
56291712700
P21
P31
P496
0000-0001-7921-3268